Logo image of WOLF.CA

GREY WOLF ANIMAL HEALTH CORP (WOLF.CA) Stock Fundamental Analysis

TSX-V:WOLF - TSX Venture Exchange - CA3978851044 - Common Stock - Currency: CAD

1.01  0 (0%)

Fundamental Rating

2

WOLF gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. WOLF may be in some trouble as it scores bad on both profitability and health. WOLF has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

WOLF had positive earnings in the past year.
In the past year WOLF had a positive cash flow from operations.
WOLF.CA Yearly Net Income VS EBIT VS OCF VS FCFWOLF.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M 2M

1.2 Ratios

Industry RankSector Rank
ROA 1.08%
ROE 2.44%
ROIC 1.66%
ROA(3y)3.02%
ROA(5y)N/A
ROE(3y)5.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WOLF.CA Yearly ROA, ROE, ROICWOLF.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

In the last couple of years the Operating Margin of WOLF has grown nicely.
WOLF's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.1%
PM (TTM) 2.63%
GM 51.28%
OM growth 3Y136.87%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.06%
GM growth 5YN/A
WOLF.CA Yearly Profit, Operating, Gross MarginsWOLF.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 40

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), WOLF is destroying value.
WOLF has more shares outstanding than it did 1 year ago.
The debt/assets ratio for WOLF is higher compared to a year ago.
WOLF.CA Yearly Shares OutstandingWOLF.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
WOLF.CA Yearly Total Debt VS Total AssetsWOLF.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of 1.14, we must say that WOLF is in the distress zone and has some risk of bankruptcy.
The Debt to FCF ratio of WOLF is 6.89, which is on the high side as it means it would take WOLF, 6.89 years of fcf income to pay off all of its debts.
WOLF has a Debt/Equity ratio of 0.94. This is a neutral value indicating WOLF is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 6.89
Altman-Z 1.14
ROIC/WACC0.26
WACC6.27%
WOLF.CA Yearly LT Debt VS Equity VS FCFWOLF.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M 10M 15M 20M 25M

2.3 Liquidity

A Current Ratio of 2.34 indicates that WOLF has no problem at all paying its short term obligations.
WOLF has a Quick Ratio of 1.45. This is a normal value and indicates that WOLF is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 1.45
WOLF.CA Yearly Current Assets VS Current LiabilitesWOLF.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

WOLF shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.10%.
Looking at the last year, WOLF shows a small growth in Revenue. The Revenue has grown by 5.58% in the last year.
Measured over the past years, WOLF shows a very strong growth in Revenue. The Revenue has been growing by 26.99% on average per year.
EPS 1Y (TTM)5.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.49%
Revenue 1Y (TTM)5.58%
Revenue growth 3Y26.99%
Revenue growth 5YN/A
Sales Q2Q%31.01%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WOLF.CA Yearly Revenue VS EstimatesWOLF.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 50.50, which means the current valuation is very expensive for WOLF.
WOLF is valuated expensively when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 50.5
Fwd PE N/A
WOLF.CA Price Earnings VS Forward Price EarningsWOLF.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 8.77
EV/EBITDA 14.08
WOLF.CA Per share dataWOLF.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

WOLF does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GREY WOLF ANIMAL HEALTH CORP

TSX-V:WOLF (7/11/2025, 7:00:00 PM)

1.01

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-22 2025-05-22
Earnings (Next)08-21 2025-08-21
Inst Owners10.55%
Inst Owner ChangeN/A
Ins Owners12.91%
Ins Owner ChangeN/A
Market Cap34.53M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 50.5
Fwd PE N/A
P/S 1.29
P/FCF 8.77
P/OCF 7.48
P/B 1.2
P/tB N/A
EV/EBITDA 14.08
EPS(TTM)0.02
EY1.98%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.12
FCFY11.4%
OCF(TTM)0.14
OCFY13.37%
SpS0.78
BVpS0.84
TBVpS-0.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.08%
ROE 2.44%
ROCE 3.24%
ROIC 1.66%
ROICexc 1.87%
ROICexgc 8.41%
OM 7.1%
PM (TTM) 2.63%
GM 51.28%
FCFM 14.67%
ROA(3y)3.02%
ROA(5y)N/A
ROE(3y)5.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y125.9%
ROICexc growth 5YN/A
OM growth 3Y136.87%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.06%
GM growth 5YN/A
F-Score5
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 6.89
Debt/EBITDA 7.21
Cap/Depr 36.91%
Cap/Sales 2.54%
Interest Coverage 2.53
Cash Conversion 123.14%
Profit Quality 558.61%
Current Ratio 2.34
Quick Ratio 1.45
Altman-Z 1.14
F-Score5
WACC6.27%
ROIC/WACC0.26
Cap/Depr(3y)19.25%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.11%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-80.49%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.58%
Revenue growth 3Y26.99%
Revenue growth 5YN/A
Sales Q2Q%31.01%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.54%
EBIT growth 3Y200.8%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y631.96%
FCF growth 3Y-16.99%
FCF growth 5YN/A
OCF growth 1Y759.63%
OCF growth 3Y-6.55%
OCF growth 5YN/A